Author:
Wang Jian,Lon Hoi-Kei,Lee Shwu-Luan,Burckart Gilbert J.,Pisetsky David S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference66 articles.
1. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012;19(1):60–71.
2. Tremblay GA, Oldfield PR. Bioanalysis of siRNA and oligonucleotide therapeutics in biological fluids and tissues. Bioanalysis. 2009;1(3):595–609.
3. Lee SL, Brown P, Wang J, Dorsam RT. Nonclinical safety assessments and clinical pharmacokinetics for oligonucleotide therapeutics: a regulatory perspective. In: Cheng K, Mahato RI, eds. Advanced Delivery and Therapeutic Applications of RNAi. Hoboken, NJ: Wiley; 2013:63–82.
4. Geary RS, Watanabe TA, Truong L, et al. Pharmacokinetic properties of 2′-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats. J Pharmacol Exp Ther. 2001;296(3):890–897.
5. Geary RS. Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin Drug Metab Toxicol. 2009;5(4):381–391.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献